High expression levels of DDIT4 protein have been observed in ovarian cancer (OC)31, bladder urothelial carcinoma (BUC)30, ccRCC (patients with von Hippel Lindau-deficient)27, and gastric cancer (GC)22 tissues compared to adjacent normal tissues. Here, DDIT4 is linked to nonpapillary renal cell carcinoma.